Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Aug 2024 for Prokidney CORP.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Todd C. Girolamo: trading record in brief
Todd C. Girolamo (senior executive) discloses dealings in 3 companies, chiefly Lisata Therapeutics, Inc., Prokidney Corp. and Longeveron Inc. Between 10 January 2022 and 31 July 2024, the trades on record add up to 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 2 August 2024 came the latest disclosure, a transaction in Prokidney Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Todd C. Girolamo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
81,928 shares0Class A Ordinary SharesSEC:0000950170-24-089935:0
81,928 shares0Class A Ordinary SharesSEC:0000950170-24-011720:0
5,000 shares0Common stockSEC:0001214659-22-003245:0
2,563 shares@ US$0.8063100.0% of flowCommon StockSEC:0001891257-22-000004:0
129,000 shares0Common StockSEC:0001891257-22-000002:0
5 of 5 declarations
